Compass Therapeutics (CMPX) Retained Earnings (2018 - 2026)
Compass Therapeutics (CMPX) posted Retained Earnings of -$159000.0 for Q1 2026, down 156.79% sequentially from $280000.0 in Q4 2025, and down 183.68% YoY from $190000.0 in Q1 2025.
Compass Therapeutics (CMPX) Retained Earnings (2018 - 2026) Analysis & Trends
Compass Therapeutics has reported Retained Earnings for 9 years, with the latest figure at -$159000.0 in Q1 2026.
- Quarterly Retained Earnings fell 183.68% year-over-year to -$159000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$159000.0 (down 183.68% YoY) and the FY2025 annual result came in at $280000.0, up 33.33% from the prior year.
- Retained Earnings retreated to -$159000.0 in Q1 2026 per CMPX's latest filing, from $280000.0 in the prior quarter.
- Over five years, Retained Earnings peaked at $280000.0 in Q4 2025 and troughed at -$349.7 million in Q3 2024.
- A 5-year average of -$90.3 million and a median of -$302000.0 in 2022 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings sank 223252.74% in 2024, then surged 328.57% in 2025.
- Over 5 years, Retained Earnings stood at -$302000.0 in 2022, then tumbled by 104306.62% to -$315.3 million in 2023, then soared by 100.07% to $210000.0 in 2024, then jumped by 33.33% to $280000.0 in 2025, then sank by 156.79% to -$159000.0 in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered -$159000.0, $280000.0, and $274000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Compass Therapeutics | 405.20 Mn | 405.20 Mn | - | -474.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -474.64 Mn |
| Mar 31, 2026 | -159,000.00 |
| Dec 31, 2025 | 280,000.00 |
| Sep 30, 2025 | 274,000.00 |
| Jun 30, 2025 | 208,000.00 |
| Mar 31, 2025 | 190,000.00 |
| Dec 31, 2024 | 210,000.00 |
| Sep 30, 2024 | -349.65 Mn |
| Jun 30, 2024 | -91,000.00 |
| Mar 31, 2024 | -326.10 Mn |
| Dec 31, 2023 | -315.31 Mn |
| Sep 30, 2023 | -301.89 Mn |
| Jun 30, 2023 | -507,000.00 |
| Mar 31, 2023 | -146,000.00 |
| Dec 31, 2022 | -302,000.00 |
| Sep 30, 2022 | -641,000.00 |
| Jun 30, 2022 | -512,000.00 |
| Mar 31, 2022 | -240.75 Mn |
| Dec 31, 2021 | -233.59 Mn |
| Sep 30, 2021 | -220.61 Mn |